Europe Surgical Needles Market Size, Trends & Growth Opportunity By Needle Type, By Suture Compatibility, By Surgical Specialty, By End User, By Region and Forecast Till 2030

Report ID : AMR1006237 | Industries : Healthcare | Published On :October 2026 | Page Count : 299

Request Sample
Ask for Customization

Europe Surgical Needles Market Overview & Definition

The Europe surgical needles market covers surgical (suture) needles, both eyed and swaged, supplied to European human and veterinary surgical settings across Western Europe, Southern Europe, the Nordic Region, and Central and Eastern Europe.

It excludes hypodermic and syringe needles, biopsy needles and endoscopic or robotic instruments, so the figures in this report describe a procedure-linked surgical consumable category and nothing wider.

A surgical needle is the metal point that carries suture material through tissue, and this report describes the category strictly as a set of market segments. It makes no clinical, safety or efficacy claim about any needle, suture or company, and it does not describe what any regulation requires.

Eleven segmentation dimensions structure the report, and the first four describe the product itself: surgical needle type, needle curvature, needle size and attachment type.

Surgical needle type spans seven categories, from taper point, cutting and reverse cutting needles to blunt point, spatula, trocar point and specialty needles. Needle curvature spans five categories, from quarter circle to five-eighths circle and compound curvature, and needle size spans micro, standard and large.

Attachment type separates eyed needles from eyeless (swaged) needles, in which the suture is permanently joined to the needle. Suture compatibility adds three categories: absorbable, non-absorbable and specialty suture systems.

The remaining dimensions describe demand and routes to market. Surgical specialty spans ten categories and procedure complexity three, while end user spans seven categories, procurement model five, regulatory classification three and distribution channel four.

The most useful commercial observation is that a needle and its suture are bought as one unit, so a European buyer classifies a swaged needle by the pairing rather than by the needle alone.

A second observation is that the procurement model, not the end user type alone, decides how a purchase actually happens. A public hospital buying through a regional tender and a public hospital buying through a distributor face two different commercial situations.

Geography is organised as a single European footprint of four sub-regions, with country and city coverage in the full report.

Market Size & Growth Forecast (2025 to 2030)

The Europe surgical needles market is estimated at approximately USD 142 Million in 2025 and is projected to reach approximately USD 177 Million by 2030, expanding at a compound annual growth rate of roughly 4.5 percent.

The estimate is a top-down derivation from the wider surgical suture category, and the Research Methodology section sets out each step and the analyst assumptions behind it.

It covers surgical needles supplied to European human and veterinary surgical settings and excludes hypodermic and syringe needles, biopsy needles and endoscopic or robotic instruments.

Absorbable suture needles account for the largest suture compatibility category and are also expected to be the fastest-growing category within it, in line with the wider European suture category.

General surgery accounts for the largest surgical specialty category, reflecting the breadth and frequency of general surgical procedures.

Microsurgical procedures form the fastest-growing procedure complexity category, supported by growth in advanced procedures that use micro-sized, compound curvature and specialty needles.

Public hospitals account for the largest end user category, and regional tender programmes and hospital procurement networks are important routes through which they buy.

Western Europe accounts for the largest regional concentration, given the scale of its hospital systems and surgical volumes.

Growth is steady rather than rapid. Surgical needles are a procedure-linked consumable, so the trajectory follows surgical volumes and replenishment cycles more closely than it follows product launches.

The forecast assumes European surgical procedure volumes continue broadly on recent trends. A sustained change in elective surgery activity, or a major shift in how public tenders are run, would move the trajectory.

MetricValue
Market Size (2025)Approximately USD 142 Million
Forecast Size (2030)Approximately USD 177 Million
CAGR (2025-2030)Approximately 4.5%
Base Year2025
Forecast Period2026-2030 (5-year)
Scope NoteSurgical (suture) needles, eyed and swaged, only; excludes hypodermic and syringe needles, biopsy needles and endoscopic or robotic instruments
Largest Suture Compatibility CategoryAbsorbable suture needles
Fastest-Growing Suture Compatibility CategoryAbsorbable suture needles
Largest Surgical Specialty CategoryGeneral surgery
Fastest-Growing Procedure Complexity CategoryMicrosurgical procedures
Largest End User CategoryPublic hospitals
Largest Regional ConcentrationWestern Europe

 

Market Drivers

Four drivers shape demand for surgical needles across Europe.

Rising surgical procedure volumes across general, cardiovascular, orthopaedic and gynaecological specialties sustain steady replenishment demand for surgical needles across European hospital systems.

Growth in microsurgical and advanced procedures supports demand for micro-sized, compound curvature and specialty needle categories, which carry more demanding manufacturing requirements than standard formats.

Consolidation of hospital purchasing into national hospital groups, regional networks and framework agreements favours suppliers with broad needle and suture portfolios, since a single contract can then cover many product lines.

Continued emphasis on atraumatic needle design and needle coating technologies as differentiators in surgeon acceptance and product evaluation keeps product development active even in a mature consumable category.

Market Restraints

Four restraints temper growth.

Tender-driven public procurement across many European health systems concentrates purchasing decisions around cost reduction initiatives and compresses supplier margins.

The ongoing cost and documentation burden of maintaining Medical Device Regulation (MDR) and CE marking status across a wide product range weighs most heavily on smaller suppliers with long product catalogues.

Supply chain exposure to stainless steel wire and precision manufacturing inputs bears on production continuity and cost.

Intense competition between premium multinational suppliers, European specialty manufacturers and country-focused distributors fragments surgeon and procurement preference.

PROCUREMENT INSIGHT

Public tenders reward suppliers that can cover a broad needle and suture list at a competitive position across a whole lot, which means a strong specialty product alone rarely wins a hospital group's business without the portfolio breadth around it.

 

Market Opportunities

Four opportunities stand out in the report's competitive mapping.

Considerable untapped opportunity exists in premium specialty and microsurgical needle categories, where the supplier field is narrower than in standard formats.

Distributor coverage gaps and underserved hospital segments remain across selected European countries, particularly where suppliers rely on a single national partner.

Tender participation opportunities exist within regional and national procurement programmes for suppliers able to meet the documentation those programmes require.

Product differentiation opportunities exist in advanced needle coatings and in adaptation of needle formats to robotic surgery.

MARKET SHIFT

As microsurgical and advanced procedures grow within the surgical mix, the gap between commodity needle formats and precision specialty formats is widening, and suppliers that can serve both ends of that range are better placed than those confined to one.

 

Surgical Needle Types, Curvatures and Sizes

Surgical needle type, needle curvature and needle size together define the physical product range, and type is the first of the three decisions a buyer makes.

Seven type categories, five curvature categories and three size categories combine into a catalogue that is easiest to read through needle types, curvatures and sizes, where each category is described as a product and market segment only.

Suture Compatibility, Attachment Types and Regulatory Classifications

Suture compatibility, attachment type and regulatory classification describe how a needle is paired with its suture and under which market-access category it is offered.

Because swaged needles reach the buyer as a single combined unit, the classification logic is clearest in suture compatibility and regulatory classifications, which treat MDR-compliant, CE-marked and specialty certified devices as market-access categories only.

Surgical Specialties and Procedure Complexity

Ten surgical specialty categories and three procedure complexity categories describe where European surgical needle demand originates.

Demand differs by specialty and by procedure complexity within each specialty, a distinction explored in surgical specialties and procedure complexity, from routine closure to microsurgical work.

End Users, Procurement Models and Distribution Channels

Seven end user categories, five procurement models and four distribution channels describe who buys surgical needles and how the purchase is organised.

The route a purchase takes often matters more than the buyer's type, a point developed through end users, procurement models and distribution channels, each set out in turn.

Europe Surgical Needles Market, By Region

This report covers Europe as a single footprint made up of four sub-regions: Western Europe, Southern Europe, the Nordic Region, and Central and Eastern Europe.

Western Europe is the largest regional concentration and is covered through France, Germany, the United Kingdom, the Netherlands, Belgium, Switzerland and Austria, with surgical demand concentrated around large hospital systems and academic centres in major cities.

Southern Europe is covered through Italy, Spain and Portugal, where regional health authorities and regional tender programmes play a prominent role in how hospitals buy.

The Nordic Region is covered through Sweden, Denmark, Norway and Finland, markets with centralised public healthcare systems in which national and regional framework agreements shape supply.

Central and Eastern Europe is covered through Poland, the Czech Republic, Hungary and Romania, where hospital infrastructure investment and expanding surgical capacity support procedure growth.

City-level coverage in the full report includes Paris, Lyon, Berlin, Munich, London, Milan, Madrid, Stockholm, Warsaw and Prague among others.

Regional sizing, growth rates and country or city-level breakdowns are reserved for the full report rather than presented on this page.

REGIONAL OPPORTUNITY

Procurement intensity differs sharply between countries that buy through national tenders and those that buy through regional authorities or hospital networks, so the same product can face very different entry conditions within a single European region.

 

Leading Companies

The supplier landscape spans premium multinational suppliers, integrated suture and needle manufacturers, European specialty manufacturers, niche surgical device suppliers, country-focused distributors and tender-focused suppliers.

Each type competes differently on portfolio breadth, specialty coverage and tender participation, which is why the leading surgical needle manufacturers in Europe are described by supplier type rather than ranked.

Beyond This Page

The full report extends well past the segmentation summarised here and into the commercial detail that shapes how surgical needle supply is actually won across European hospitals.

Buyer intelligence maps buyer segmentation, buyer scale, procurement models, buying triggers, decision-maker roles, budget ownership and vendor selection criteria in full, including a dedicated strategic relevance assessment for SUTUREX & RENODEX.

Country-wise buyer mapping covers France, Germany, Italy, Spain, the United Kingdom, Benelux, the Nordics and Central Europe, alongside contract value bands and sales cycle length.

Competitive benchmarking compares suppliers across estimated market position, product portfolio breadth, specialty coverage, distribution reach, hospital penetration, tender success rate and regulatory certifications.

The market playbook covers manufacturing economics, raw material considerations, the effect of European MDR and CE compliance on suppliers, and technology disruption from advanced coatings and robotic surgery.

Pricing and procurement chapters cover the procurement lifecycle, buyer and supplier power, and total cost of ownership, and go-to-market chapters cover entry pathways, distributor and partner mapping and trade events.

Company profiles cover fourteen suppliers across geographic footprint, product portfolio, target customers, distribution model, certifications, partnerships, research and development and recent developments.

Frequently Asked Questions

The Europe surgical needles market is estimated at approximately USD 142 Million in 2025 and is projected to reach approximately USD 177 Million by 2030, a compound annual growth rate of roughly 4.5 percent.

The report uses eleven dimensions: needle type, curvature, size, attachment type, suture compatibility, surgical specialty, procedure complexity, end user, procurement model, regulatory classification and distribution channel.

Europe is covered as four sub-regions, Western Europe, Southern Europe, the Nordic Region, and Central and Eastern Europe, with country and city coverage across eighteen countries in the full report.

It excludes hypodermic and syringe needles, biopsy needles and endoscopic or robotic instruments, and it covers surgical (suture) needles only.

An eyeless needle in which the suture is permanently joined to the needle, so the two are supplied as one unit. Eyed needles are the other attachment type tracked in this report.

Through direct manufacturer contracts, group purchasing organisations, hospital procurement networks, regional tender programmes and distributor-led procurement, which are the five procurement models tracked in this report.

Fourteen suppliers are profiled, including B. Braun, SUTUREX & RENODEX, Johnson & Johnson MedTech, Medtronic, Peters Surgical, Corza Medical and Teleflex, described by supplier type rather than ranked.

By a top-down derivation from published estimates for the global suture needle category and the European suture category, using analyst assumptions that are set out in the Research Methodology section.

Inquire Before Buying Request Free Sample Ask For Discount

1. Introduction

1.1. Objective of the Study

1.2. Market Definition

1.3. Market Scope

2. Executive Summary

3. Europe Surgical Needles Market Analysis and Forecast (2026–2030)

3.1. Overview

3.2. Market Dynamics

3.3. Drivers

3.3.1. Rising Surgical Procedure Volumes Across General, Cardiovascular, Orthopaedic and Gynaecological Specialties, Which Sustain Steady Replenishment Demand for Surgical Needles Across European Hospital Systems.

3.3.2. Growth in Microsurgical and Advanced Procedures, Which Supports Demand for Micro-Sized, Compound Curvature and Specialty Needle Categories.

3.3.3. Consolidation of Hospital Purchasing into National Hospital Groups, Regional Networks and Framework Agreements, Which Favours Suppliers with Broad Needle and Suture Portfolios.

3.3.4. Continued Emphasis on Atraumatic Needle Design and Needle Coating Technologies as Differentiators in Surgeon Acceptance and Product Evaluation.

3.4. Restraints

3.4.1. Tender-Driven Public Procurement Across Many European Health Systems, Which Concentrates Purchasing Decisions Around Cost Reduction Initiatives and Compresses Supplier Margins.

3.4.2. The Ongoing Cost and Documentation Burden of Maintaining Medical Device Regulation (MDR) and CE Marking Status Across a Wide Product Range.

3.4.3. Supply Chain Exposure to Stainless Steel Wire and Precision Manufacturing Inputs, Which Bears on Production Continuity and Cost.

3.4.4. Intense Competition Between Premium Multinational Suppliers, European Specialty Manufacturers and Country-Focused Distributors, Which Fragments Surgeon and Procurement Preference.

3.5. Opportunities

3.5.1. Considerable Untapped Opportunity Identified in the Report Competitive Mapping for Premium Specialty and Microsurgical Needle Categories.

3.5.2. Distributor Coverage Gaps and Underserved Hospital Segments Across Selected European Countries.

3.5.3. Tender Participation Opportunities Within Regional and National Procurement Programmes.

3.5.4. Product Differentiation Opportunities in Advanced Needle Coatings and Robotic Surgery Adaptation.

3.6. Porter's Five Forces Model

3.7. Value Chain Analysis

4. Surgical Needle Type

4.1. Taper Point Needles

4.2. Cutting Needles

4.3. Reverse Cutting Needles

4.4. Blunt Point Needles

4.5. Spatula Needles

4.6. Trocar Point Needles

4.7. Specialty Needles

5. Needle Curvature

5.1. 1/4 Circle

5.2. 3/8 Circle

5.3. 1/2 Circle

5.4. 5/8 Circle

5.5. Compound Curvature Needles

6. Needle Size

6.1. Micro Surgical Needles

6.2. Standard Surgical Needles

6.3. Large Surgical Needles

7. Attachment Type

7.1. Eyed Needles

7.2. Eyeless (Swaged) Needles

8. Suture Compatibility

8.1. Absorbable Suture Needles

8.2. Non-Absorbable Suture Needles

8.3. Specialty Suture Systems

9. Surgical Specialty

9.1. General Surgery

9.2. Cardiovascular Surgery

9.3. Orthopaedic Surgery

9.4. Plastic and Reconstructive Surgery

9.5. Ophthalmic Surgery

9.6. Gynaecological Surgery

9.7. Urological Surgery

9.8. Gastrointestinal Surgery

9.9. Neurosurgery

9.10. Veterinary Surgery

10. Procedure Complexity

10.1. Routine Surgical Procedures

10.2. Advanced Surgical Procedures

10.3. Microsurgical Procedures

11. End User

11.1. Public Hospitals

11.2. Private Hospitals

11.3. University Hospitals

11.4. Specialty Surgical Centres

11.5. Ambulatory Surgical Centres

11.6. Military Hospitals

11.7. Veterinary Surgical Centres

12. Procurement Model

12.1. Direct Manufacturer Contracts

12.2. Group Purchasing Organizations (GPOs)

12.3. Hospital Procurement Networks

12.4. Regional Tender Programmes

12.5. Distributor-Led Procurement

13. Regulatory Classification

13.1. Medical Device Regulation (MDR)-Compliant Surgical Needles

13.2. CE-Marked Surgical Needles

13.3. Specialty Certified Surgical Devices

14. Distribution Channel

14.1. Direct Sales

14.2. Medical Device Distributors

14.3. Surgical Product Specialists

14.4. Tender-Based Supply Networks

15. Buyer Intelligence and Demand Landscape

15.1. Buyer Segmentation

15.1.1. Public Healthcare Systems

15.1.2. Private Healthcare Networks

15.1.3. Academic Medical Centres

15.1.4. Specialty Surgical Hospitals

15.1.5. Ambulatory Surgery Centres

15.2. Buyer Industries

15.2.1. Healthcare Providers

15.2.2. Surgical Care Providers

15.2.3. Specialty Medical Facilities

15.2.4. Veterinary Healthcare Providers

15.3. Buyer Company Types

15.3.1. Multi-Hospital Groups

15.3.2. Independent Hospitals

15.3.3. University Hospitals

15.3.4. Specialty Clinics

15.4. Country-Wise Buyer Mapping

15.4.1. France

15.4.2. Germany

15.4.3. Italy

15.4.4. Spain

15.4.5. United Kingdom

15.4.6. Benelux

15.4.7. Nordics

15.4.8. Central Europe

15.5. Regional Demand Clusters

15.5.1. Western European Surgical Hubs

15.5.2. High-Volume Academic Centres

15.5.3. Advanced Specialty Surgery Clusters

15.6. Buyer Scale Classification

15.6.1. National Hospital Groups

15.6.2. Regional Hospital Networks

15.6.3. Independent Facilities

15.7. Procurement Models

15.7.1. National Tenders

15.7.2. Regional Tenders

15.7.3. Framework Agreements

15.7.4. Distributor Procurement

15.7.5. Direct Contracting

15.8. Buying Triggers

15.8.1. Surgical Volume Growth

15.8.2. Product Performance Requirements

15.8.3. Cost Reduction Initiatives

15.8.4. Surgeon Preference

15.8.5. Regulatory Compliance

15.9. Decision-Maker Roles

15.9.1. Chief Procurement Officer

15.9.2. Head of Surgical Procurement

15.9.3. Operating Room Director

15.9.4. Chief Medical Officer

15.9.5. Surgical Department Heads

15.9.6. Clinical Evaluation Committees

15.10. Budget Ownership

15.10.1. Hospital Procurement Teams

15.10.2. Surgical Departments

15.10.3. Healthcare Networks

15.10.4. Government Procurement Bodies

15.11. Vendor Selection Criteria

15.11.1. Needle Quality

15.11.2. Surgeon Acceptance

15.11.3. Clinical Performance

15.11.4. Regulatory Compliance

15.11.5. Pricing Competitiveness

15.11.6. Supply Reliability

15.12. Contract Value Bands

15.12.1. Small Hospital Contracts

15.12.2. Regional Framework Agreements

15.12.3. National Procurement Contracts

15.13. Sales Cycle Length

15.13.1. Immediate Replenishment Purchases

15.13.2. Annual Contract Renewals

15.13.3. Multi-Year Tender Agreements

15.14. Strategic Relevance for SUTUREX & RENODEX

15.14.1. Premium Specialty Needle Opportunities

15.14.2. Hospital Conversion Potential

15.14.3. Distributor Expansion Opportunities

15.14.4. Tender Participation Strategies

16. Europe Market Analysis and Forecast (2026–2030)

16.1. Introduction

16.2. Market Share Analysis

16.3. Market Size and Forecast

16.4. Market Size and Forecast, By Geography

16.4.1. Western Europe

16.4.1.1. Market Share Analysis

16.4.1.2. Market Size and Forecast

16.4.1.3. By Product

16.4.1.4. By Technology

16.4.1.5. By Application

16.4.1.6. By Customer

16.4.1.7. France

16.4.1.7.1. Market Share Analysis

16.4.1.7.2. Market Size and Forecast

16.4.1.7.3. By Product

16.4.1.7.4. By Technology

16.4.1.7.5. By Application

16.4.1.7.6. By Customer

16.4.1.7.7. Paris

16.4.1.7.7.1. Market Share Analysis

16.4.1.7.7.2. Market Size and Forecast

16.4.1.7.7.3. By Product

16.4.1.7.7.4. By Technology

16.4.1.7.7.5. By Application

16.4.1.7.7.6. By Customer

16.4.1.7.8. Lyon

16.4.1.7.8.1. Market Share Analysis

16.4.1.7.8.2. Market Size and Forecast

16.4.1.7.8.3. By Product

16.4.1.7.8.4. By Technology

16.4.1.7.8.5. By Application

16.4.1.7.8.6. By Customer

16.4.1.7.9. Marseille

16.4.1.7.9.1. Market Share Analysis

16.4.1.7.9.2. Market Size and Forecast

16.4.1.7.9.3. By Product

16.4.1.7.9.4. By Technology

16.4.1.7.9.5. By Application

16.4.1.7.9.6. By Customer

16.4.1.7.10. Lille

16.4.1.7.10.1. Market Share Analysis

16.4.1.7.10.2. Market Size and Forecast

16.4.1.7.10.3. By Product

16.4.1.7.10.4. By Technology

16.4.1.7.10.5. By Application

16.4.1.7.10.6. By Customer

16.4.1.7.11. Toulouse

16.4.1.7.11.1. Market Share Analysis

16.4.1.7.11.2. Market Size and Forecast

16.4.1.7.11.3. By Product

16.4.1.7.11.4. By Technology

16.4.1.7.11.5. By Application

16.4.1.7.11.6. By Customer

16.4.1.8. Germany

16.4.1.8.1. Market Share Analysis

16.4.1.8.2. Market Size and Forecast

16.4.1.8.3. By Product

16.4.1.8.4. By Technology

16.4.1.8.5. By Application

16.4.1.8.6. By Customer

16.4.1.8.7. Berlin

16.4.1.8.7.1. Market Share Analysis

16.4.1.8.7.2. Market Size and Forecast

16.4.1.8.7.3. By Product

16.4.1.8.7.4. By Technology

16.4.1.8.7.5. By Application

16.4.1.8.7.6. By Customer

16.4.1.8.8. Munich

16.4.1.8.8.1. Market Share Analysis

16.4.1.8.8.2. Market Size and Forecast

16.4.1.8.8.3. By Product

16.4.1.8.8.4. By Technology

16.4.1.8.8.5. By Application

16.4.1.8.8.6. By Customer

16.4.1.8.9. Hamburg

16.4.1.8.9.1. Market Share Analysis

16.4.1.8.9.2. Market Size and Forecast

16.4.1.8.9.3. By Product

16.4.1.8.9.4. By Technology

16.4.1.8.9.5. By Application

16.4.1.8.9.6. By Customer

16.4.1.8.10. Frankfurt

16.4.1.8.10.1. Market Share Analysis

16.4.1.8.10.2. Market Size and Forecast

16.4.1.8.10.3. By Product

16.4.1.8.10.4. By Technology

16.4.1.8.10.5. By Application

16.4.1.8.10.6. By Customer

16.4.1.9. United Kingdom

16.4.1.9.1. Market Share Analysis

16.4.1.9.2. Market Size and Forecast

16.4.1.9.3. By Product

16.4.1.9.4. By Technology

16.4.1.9.5. By Application

16.4.1.9.6. By Customer

16.4.1.9.7. London

16.4.1.9.7.1. Market Share Analysis

16.4.1.9.7.2. Market Size and Forecast

16.4.1.9.7.3. By Product

16.4.1.9.7.4. By Technology

16.4.1.9.7.5. By Application

16.4.1.9.7.6. By Customer

16.4.1.9.8. Manchester

16.4.1.9.8.1. Market Share Analysis

16.4.1.9.8.2. Market Size and Forecast

16.4.1.9.8.3. By Product

16.4.1.9.8.4. By Technology

16.4.1.9.8.5. By Application

16.4.1.9.8.6. By Customer

16.4.1.9.9. Birmingham

16.4.1.9.9.1. Market Share Analysis

16.4.1.9.9.2. Market Size and Forecast

16.4.1.9.9.3. By Product

16.4.1.9.9.4. By Technology

16.4.1.9.9.5. By Application

16.4.1.9.9.6. By Customer

16.4.1.10. Netherlands

16.4.1.10.1. Market Share Analysis

16.4.1.10.2. Market Size and Forecast

16.4.1.10.3. By Product

16.4.1.10.4. By Technology

16.4.1.10.5. By Application

16.4.1.10.6. By Customer

16.4.1.10.7. Amsterdam

16.4.1.10.7.1. Market Share Analysis

16.4.1.10.7.2. Market Size and Forecast

16.4.1.10.7.3. By Product

16.4.1.10.7.4. By Technology

16.4.1.10.7.5. By Application

16.4.1.10.7.6. By Customer

16.4.1.10.8. Rotterdam

16.4.1.10.8.1. Market Share Analysis

16.4.1.10.8.2. Market Size and Forecast

16.4.1.10.8.3. By Product

16.4.1.10.8.4. By Technology

16.4.1.10.8.5. By Application

16.4.1.10.8.6. By Customer

16.4.1.11. Belgium

16.4.1.11.1. Market Share Analysis

16.4.1.11.2. Market Size and Forecast

16.4.1.11.3. By Product

16.4.1.11.4. By Technology

16.4.1.11.5. By Application

16.4.1.11.6. By Customer

16.4.1.11.7. Brussels

16.4.1.11.7.1. Market Share Analysis

16.4.1.11.7.2. Market Size and Forecast

16.4.1.11.7.3. By Product

16.4.1.11.7.4. By Technology

16.4.1.11.7.5. By Application

16.4.1.11.7.6. By Customer

16.4.1.11.8. Antwerp

16.4.1.11.8.1. Market Share Analysis

16.4.1.11.8.2. Market Size and Forecast

16.4.1.11.8.3. By Product

16.4.1.11.8.4. By Technology

16.4.1.11.8.5. By Application

16.4.1.11.8.6. By Customer

16.4.1.12. Switzerland

16.4.1.12.1. Market Share Analysis

16.4.1.12.2. Market Size and Forecast

16.4.1.12.3. By Product

16.4.1.12.4. By Technology

16.4.1.12.5. By Application

16.4.1.12.6. By Customer

16.4.1.12.7. Zurich

16.4.1.12.7.1. Market Share Analysis

16.4.1.12.7.2. Market Size and Forecast

16.4.1.12.7.3. By Product

16.4.1.12.7.4. By Technology

16.4.1.12.7.5. By Application

16.4.1.12.7.6. By Customer

16.4.1.12.8. Basel

16.4.1.12.8.1. Market Share Analysis

16.4.1.12.8.2. Market Size and Forecast

16.4.1.12.8.3. By Product

16.4.1.12.8.4. By Technology

16.4.1.12.8.5. By Application

16.4.1.12.8.6. By Customer

16.4.1.13. Austria

16.4.1.13.1. Market Share Analysis

16.4.1.13.2. Market Size and Forecast

16.4.1.13.3. By Product

16.4.1.13.4. By Technology

16.4.1.13.5. By Application

16.4.1.13.6. By Customer

16.4.1.13.7. Vienna

16.4.1.13.7.1. Market Share Analysis

16.4.1.13.7.2. Market Size and Forecast

16.4.1.13.7.3. By Product

16.4.1.13.7.4. By Technology

16.4.1.13.7.5. By Application

16.4.1.13.7.6. By Customer

16.4.2. Southern Europe

16.4.2.1. Market Share Analysis

16.4.2.2. Market Size and Forecast

16.4.2.3. By Product

16.4.2.4. By Technology

16.4.2.5. By Application

16.4.2.6. By Customer

16.4.2.7. Italy

16.4.2.7.1. Market Share Analysis

16.4.2.7.2. Market Size and Forecast

16.4.2.7.3. By Product

16.4.2.7.4. By Technology

16.4.2.7.5. By Application

16.4.2.7.6. By Customer

16.4.2.7.7. Milan

16.4.2.7.7.1. Market Share Analysis

16.4.2.7.7.2. Market Size and Forecast

16.4.2.7.7.3. By Product

16.4.2.7.7.4. By Technology

16.4.2.7.7.5. By Application

16.4.2.7.7.6. By Customer

16.4.2.7.8. Rome

16.4.2.7.8.1. Market Share Analysis

16.4.2.7.8.2. Market Size and Forecast

16.4.2.7.8.3. By Product

16.4.2.7.8.4. By Technology

16.4.2.7.8.5. By Application

16.4.2.7.8.6. By Customer

16.4.2.7.9. Bologna

16.4.2.7.9.1. Market Share Analysis

16.4.2.7.9.2. Market Size and Forecast

16.4.2.7.9.3. By Product

16.4.2.7.9.4. By Technology

16.4.2.7.9.5. By Application

16.4.2.7.9.6. By Customer

16.4.2.8. Spain

16.4.2.8.1. Market Share Analysis

16.4.2.8.2. Market Size and Forecast

16.4.2.8.3. By Product

16.4.2.8.4. By Technology

16.4.2.8.5. By Application

16.4.2.8.6. By Customer

16.4.2.8.7. Madrid

16.4.2.8.7.1. Market Share Analysis

16.4.2.8.7.2. Market Size and Forecast

16.4.2.8.7.3. By Product

16.4.2.8.7.4. By Technology

16.4.2.8.7.5. By Application

16.4.2.8.7.6. By Customer

16.4.2.8.8. Barcelona

16.4.2.8.8.1. Market Share Analysis

16.4.2.8.8.2. Market Size and Forecast

16.4.2.8.8.3. By Product

16.4.2.8.8.4. By Technology

16.4.2.8.8.5. By Application

16.4.2.8.8.6. By Customer

16.4.2.8.9. Valencia

16.4.2.8.9.1. Market Share Analysis

16.4.2.8.9.2. Market Size and Forecast

16.4.2.8.9.3. By Product

16.4.2.8.9.4. By Technology

16.4.2.8.9.5. By Application

16.4.2.8.9.6. By Customer

16.4.2.9. Portugal

16.4.2.9.1. Market Share Analysis

16.4.2.9.2. Market Size and Forecast

16.4.2.9.3. By Product

16.4.2.9.4. By Technology

16.4.2.9.5. By Application

16.4.2.9.6. By Customer

16.4.3. Nordic Region

16.4.3.1. Market Share Analysis

16.4.3.2. Market Size and Forecast

16.4.3.3. By Product

16.4.3.4. By Technology

16.4.3.5. By Application

16.4.3.6. By Customer

16.4.3.7. Sweden

16.4.3.7.1. Market Share Analysis

16.4.3.7.2. Market Size and Forecast

16.4.3.7.3. By Product

16.4.3.7.4. By Technology

16.4.3.7.5. By Application

16.4.3.7.6. By Customer

16.4.3.7.7. Stockholm

16.4.3.7.7.1. Market Share Analysis

16.4.3.7.7.2. Market Size and Forecast

16.4.3.7.7.3. By Product

16.4.3.7.7.4. By Technology

16.4.3.7.7.5. By Application

16.4.3.7.7.6. By Customer

16.4.3.7.8. Gothenburg

16.4.3.7.8.1. Market Share Analysis

16.4.3.7.8.2. Market Size and Forecast

16.4.3.7.8.3. By Product

16.4.3.7.8.4. By Technology

16.4.3.7.8.5. By Application

16.4.3.7.8.6. By Customer

16.4.3.8. Denmark

16.4.3.8.1. Market Share Analysis

16.4.3.8.2. Market Size and Forecast

16.4.3.8.3. By Product

16.4.3.8.4. By Technology

16.4.3.8.5. By Application

16.4.3.8.6. By Customer

16.4.3.8.7. Copenhagen

16.4.3.8.7.1. Market Share Analysis

16.4.3.8.7.2. Market Size and Forecast

16.4.3.8.7.3. By Product

16.4.3.8.7.4. By Technology

16.4.3.8.7.5. By Application

16.4.3.8.7.6. By Customer

16.4.3.9. Norway

16.4.3.9.1. Market Share Analysis

16.4.3.9.2. Market Size and Forecast

16.4.3.9.3. By Product

16.4.3.9.4. By Technology

16.4.3.9.5. By Application

16.4.3.9.6. By Customer

16.4.3.9.7. Oslo

16.4.3.9.7.1. Market Share Analysis

16.4.3.9.7.2. Market Size and Forecast

16.4.3.9.7.3. By Product

16.4.3.9.7.4. By Technology

16.4.3.9.7.5. By Application

16.4.3.9.7.6. By Customer

16.4.3.10. Finland

16.4.3.10.1. Market Share Analysis

16.4.3.10.2. Market Size and Forecast

16.4.3.10.3. By Product

16.4.3.10.4. By Technology

16.4.3.10.5. By Application

16.4.3.10.6. By Customer

16.4.4. Central and Eastern Europe

16.4.4.1. Market Share Analysis

16.4.4.2. Market Size and Forecast

16.4.4.3. By Product

16.4.4.4. By Technology

16.4.4.5. By Application

16.4.4.6. By Customer

16.4.4.7. Poland

16.4.4.7.1. Market Share Analysis

16.4.4.7.2. Market Size and Forecast

16.4.4.7.3. By Product

16.4.4.7.4. By Technology

16.4.4.7.5. By Application

16.4.4.7.6. By Customer

16.4.4.7.7. Warsaw

16.4.4.7.7.1. Market Share Analysis

16.4.4.7.7.2. Market Size and Forecast

16.4.4.7.7.3. By Product

16.4.4.7.7.4. By Technology

16.4.4.7.7.5. By Application

16.4.4.7.7.6. By Customer

16.4.4.7.8. Krakow

16.4.4.7.8.1. Market Share Analysis

16.4.4.7.8.2. Market Size and Forecast

16.4.4.7.8.3. By Product

16.4.4.7.8.4. By Technology

16.4.4.7.8.5. By Application

16.4.4.7.8.6. By Customer

16.4.4.8. Czech Republic

16.4.4.8.1. Market Share Analysis

16.4.4.8.2. Market Size and Forecast

16.4.4.8.3. By Product

16.4.4.8.4. By Technology

16.4.4.8.5. By Application

16.4.4.8.6. By Customer

16.4.4.8.7. Prague

16.4.4.8.7.1. Market Share Analysis

16.4.4.8.7.2. Market Size and Forecast

16.4.4.8.7.3. By Product

16.4.4.8.7.4. By Technology

16.4.4.8.7.5. By Application

16.4.4.8.7.6. By Customer

16.4.4.9. Hungary

16.4.4.9.1. Market Share Analysis

16.4.4.9.2. Market Size and Forecast

16.4.4.9.3. By Product

16.4.4.9.4. By Technology

16.4.4.9.5. By Application

16.4.4.9.6. By Customer

16.4.4.9.7. Budapest

16.4.4.9.7.1. Market Share Analysis

16.4.4.9.7.2. Market Size and Forecast

16.4.4.9.7.3. By Product

16.4.4.9.7.4. By Technology

16.4.4.9.7.5. By Application

16.4.4.9.7.6. By Customer

16.4.4.10. Romania

16.4.4.10.1. Market Share Analysis

16.4.4.10.2. Market Size and Forecast

16.4.4.10.3. By Product

16.4.4.10.4. By Technology

16.4.4.10.5. By Application

16.4.4.10.6. By Customer

16.5. Qualitative Market Insights

16.5.1. Procedure Volume Analysis

16.5.2. Hospital Infrastructure Mapping

16.5.3. Surgical Specialty Demand Clusters

16.5.4. Procurement Intensity Assessment

16.5.5. Competitive Penetration Analysis

17. Competition Analysis

17.1. Market Positioning Overview

17.1.1. Global Positioning

17.1.1.1. Premium Multinational Suppliers

17.1.1.2. Integrated Suture and Needle Manufacturers

17.1.2. Regional Positioning

17.1.2.1. European Specialty Manufacturers

17.1.2.2. Niche Surgical Device Suppliers

17.1.3. Local Positioning

17.1.3.1. Country-Focused Distributors

17.1.3.2. Tender-Focused Suppliers

17.1.4. Value Proposition Tiers

17.1.4.1. Economy

17.1.4.2. Mid-Market

17.1.4.3. Premium

17.1.4.4. Specialty Surgical

17.1.5. Target Segments

17.1.5.1. High-Volume Hospitals

17.1.5.2. Specialty Surgery Centres

17.1.5.3. Academic Institutions

17.1.6. Technology Differentiation

17.1.6.1. Precision Manufacturing

17.1.6.2. Needle Coating Technologies

17.1.6.3. Atraumatic Needle Design

17.1.6.4. Microsurgical Capabilities

17.2. Competitive Benchmarking Metrics

17.2.1. Estimated Market Position

17.2.2. Product Portfolio Breadth

17.2.3. Specialty Coverage

17.2.4. Pricing Tiers

17.2.5. Distribution Reach

17.2.6. Hospital Penetration

17.2.7. Tender Success Rate

17.2.8. Service Infrastructure

17.2.9. Manufacturing Capability

17.2.10. Innovation Pipeline

17.2.11. Regulatory Certifications

17.3. Strategic Moves

17.3.1. Acquisitions

17.3.2. Partnerships

17.3.3. Product Launches

17.3.4. Manufacturing Investments

17.3.5. Capacity Expansion

17.3.6. Distribution Agreements

17.3.7. Geographic Expansion Initiatives

17.4. Competitive Mapping & Gaps

17.4.1. Premium Specialty Segment Gaps

17.4.2. Microsurgery Opportunities

17.4.3. Underserved Hospital Segments

17.4.4. Distributor Coverage Gaps

17.4.5. Country-Level Untapped Opportunities

17.4.6. Tender Participation Opportunities

17.4.7. Product Differentiation Opportunities

18. Company Profiles

18.1. B. Braun

18.1.1. Overview

18.1.2. Geographic Footprint

18.1.3. Product and Service Portfolio

18.1.4. Target Customer Segments

18.1.5. Distribution and Go-to-Market Model

18.1.6. Key Financials

18.1.7. Certifications and Regulatory Compliance

18.1.8. Partnerships and Alliances

18.1.9. R&D and Innovation Initiatives

18.1.10. Recent Developments

18.1.11. SWOT Snapshot

18.2. SUTUREX & RENODEX

18.2.1. Overview

18.2.2. Geographic Footprint

18.2.3. Product and Service Portfolio

18.2.4. Target Customer Segments

18.2.5. Distribution and Go-to-Market Model

18.2.6. Key Financials

18.2.7. Certifications and Regulatory Compliance

18.2.8. Partnerships and Alliances

18.2.9. R&D and Innovation Initiatives

18.2.10. Recent Developments

18.2.11. SWOT Snapshot

18.3. Johnson & Johnson MedTech

18.3.1. Overview

18.3.2. Geographic Footprint

18.3.3. Product and Service Portfolio

18.3.4. Target Customer Segments

18.3.5. Distribution and Go-to-Market Model

18.3.6. Key Financials

18.3.7. Certifications and Regulatory Compliance

18.3.8. Partnerships and Alliances

18.3.9. R&D and Innovation Initiatives

18.3.10. Recent Developments

18.3.11. SWOT Snapshot

18.4. Medtronic

18.4.1. Overview

18.4.2. Geographic Footprint

18.4.3. Product and Service Portfolio

18.4.4. Target Customer Segments

18.4.5. Distribution and Go-to-Market Model

18.4.6. Key Financials

18.4.7. Certifications and Regulatory Compliance

18.4.8. Partnerships and Alliances

18.4.9. R&D and Innovation Initiatives

18.4.10. Recent Developments

18.4.11. SWOT Snapshot

18.5. Peters Surgical

18.5.1. Overview

18.5.2. Geographic Footprint

18.5.3. Product and Service Portfolio

18.5.4. Target Customer Segments

18.5.5. Distribution and Go-to-Market Model

18.5.6. Key Financials

18.5.7. Certifications and Regulatory Compliance

18.5.8. Partnerships and Alliances

18.5.9. R&D and Innovation Initiatives

18.5.10. Recent Developments

18.5.11. SWOT Snapshot

18.6. Corza Medical

18.6.1. Overview

18.6.2. Geographic Footprint

18.6.3. Product and Service Portfolio

18.6.4. Target Customer Segments

18.6.5. Distribution and Go-to-Market Model

18.6.6. Key Financials

18.6.7. Certifications and Regulatory Compliance

18.6.8. Partnerships and Alliances

18.6.9. R&D and Innovation Initiatives

18.6.10. Recent Developments

18.6.11. SWOT Snapshot

18.7. Teleflex

18.7.1. Overview

18.7.2. Geographic Footprint

18.7.3. Product and Service Portfolio

18.7.4. Target Customer Segments

18.7.5. Distribution and Go-to-Market Model

18.7.6. Key Financials

18.7.7. Certifications and Regulatory Compliance

18.7.8. Partnerships and Alliances

18.7.9. R&D and Innovation Initiatives

18.7.10. Recent Developments

18.7.11. SWOT Snapshot

18.8. Internacional Farmacéutica

18.8.1. Overview

18.8.2. Geographic Footprint

18.8.3. Product and Service Portfolio

18.8.4. Target Customer Segments

18.8.5. Distribution and Go-to-Market Model

18.8.6. Key Financials

18.8.7. Certifications and Regulatory Compliance

18.8.8. Partnerships and Alliances

18.8.9. R&D and Innovation Initiatives

18.8.10. Recent Developments

18.8.11. SWOT Snapshot

18.9. DemeTECH

18.9.1. Overview

18.9.2. Geographic Footprint

18.9.3. Product and Service Portfolio

18.9.4. Target Customer Segments

18.9.5. Distribution and Go-to-Market Model

18.9.6. Key Financials

18.9.7. Certifications and Regulatory Compliance

18.9.8. Partnerships and Alliances

18.9.9. R&D and Innovation Initiatives

18.9.10. Recent Developments

18.9.11. SWOT Snapshot

18.10. Advanced Medical Solutions

18.10.1. Overview

18.10.2. Geographic Footprint

18.10.3. Product and Service Portfolio

18.10.4. Target Customer Segments

18.10.5. Distribution and Go-to-Market Model

18.10.6. Key Financials

18.10.7. Certifications and Regulatory Compliance

18.10.8. Partnerships and Alliances

18.10.9. R&D and Innovation Initiatives

18.10.10. Recent Developments

18.10.11. SWOT Snapshot

18.11. Assut Europe

18.11.1. Overview

18.11.2. Geographic Footprint

18.11.3. Product and Service Portfolio

18.11.4. Target Customer Segments

18.11.5. Distribution and Go-to-Market Model

18.11.6. Key Financials

18.11.7. Certifications and Regulatory Compliance

18.11.8. Partnerships and Alliances

18.11.9. R&D and Innovation Initiatives

18.11.10. Recent Developments

18.11.11. SWOT Snapshot

18.12. Serag-Wiessner

18.12.1. Overview

18.12.2. Geographic Footprint

18.12.3. Product and Service Portfolio

18.12.4. Target Customer Segments

18.12.5. Distribution and Go-to-Market Model

18.12.6. Key Financials

18.12.7. Certifications and Regulatory Compliance

18.12.8. Partnerships and Alliances

18.12.9. R&D and Innovation Initiatives

18.12.10. Recent Developments

18.12.11. SWOT Snapshot

18.13. Smi AG

18.13.1. Overview

18.13.2. Geographic Footprint

18.13.3. Product and Service Portfolio

18.13.4. Target Customer Segments

18.13.5. Distribution and Go-to-Market Model

18.13.6. Key Financials

18.13.7. Certifications and Regulatory Compliance

18.13.8. Partnerships and Alliances

18.13.9. R&D and Innovation Initiatives

18.13.10. Recent Developments

18.13.11. SWOT Snapshot

18.14. Péters Surgical International

18.14.1. Overview

18.14.2. Geographic Footprint

18.14.3. Product and Service Portfolio

18.14.4. Target Customer Segments

18.14.5. Distribution and Go-to-Market Model

18.14.6. Key Financials

18.14.7. Certifications and Regulatory Compliance

18.14.8. Partnerships and Alliances

18.14.9. R&D and Innovation Initiatives

18.14.10. Recent Developments

18.14.11. SWOT Snapshot

Frequently Asked Questions

The Europe surgical needles market is estimated at approximately USD 142 Million in 2025 and is projected to reach approximately USD 177 Million by 2030, a compound annual growth rate of roughly 4.5 percent.

The report uses eleven dimensions: needle type, curvature, size, attachment type, suture compatibility, surgical specialty, procedure complexity, end user, procurement model, regulatory classification and distribution channel.

Europe is covered as four sub-regions, Western Europe, Southern Europe, the Nordic Region, and Central and Eastern Europe, with country and city coverage across eighteen countries in the full report.

It excludes hypodermic and syringe needles, biopsy needles and endoscopic or robotic instruments, and it covers surgical (suture) needles only.

An eyeless needle in which the suture is permanently joined to the needle, so the two are supplied as one unit. Eyed needles are the other attachment type tracked in this report.

Through direct manufacturer contracts, group purchasing organisations, hospital procurement networks, regional tender programmes and distributor-led procurement, which are the five procurement models tracked in this report.

Fourteen suppliers are profiled, including B. Braun, SUTUREX & RENODEX, Johnson & Johnson MedTech, Medtronic, Peters Surgical, Corza Medical and Teleflex, described by supplier type rather than ranked.

By a top-down derivation from published estimates for the global suture needle category and the European suture category, using analyst assumptions that are set out in the Research Methodology section.

Inquire Before Buying Request Free Sample Ask For Discount

Scope separated from hypodermic needles and the wider suture category

Surgical needles are usually reported inside the much larger surgical suture or wound closure categories, or alongside hypodermic and syringe needles, none of which are comparable with the activity described here. This estimate covers surgical (suture) needles, eyed and swaged, supplied to European human and veterinary surgical settings only. The snapshot table states that boundary so the figure is not mistaken for anything larger.

Top-down derivation from the global suture needle category

No published estimate for European surgical needles alone was found, so the figure is derived rather than measured. Published industry estimates place global suture needle sales at roughly USD 656 million in 2025. Europe accounted for approximately 22 percent of the global surgical suture category in 2025, and applying that regional share to the needle category, on the analyst assumption that needles and sutures are bought and consumed together, gives approximately USD 142 million.

Consistency check against the European suture category

Published estimates put the European surgical suture category at roughly USD 1.1 billion in 2025, and the derived needle figure equates to roughly 13 percent of that value, in line with the ratio of the global needle category to the global suture category. This supports the order of magnitude. Both inputs are adjacent-category figures and not direct measurements of European surgical needle sales, so the estimate should be read as a reasoned approximation and not as an audited figure.

Forecast basis and its principal sensitivity

The 4.5 percent growth rate follows published growth for the European surgical suture category, which sits close to published growth for the global suture needle category, and is applied as an analyst assumption to reach approximately USD 177 million in 2030. Largest and fastest-growing category statements reflect adjacent suture category evidence and analyst assessment of procedure mix and not audited segment data. Elective surgical volumes and the pace of public tender purchasing are the material sensitivities.

Frequently Asked Questions

The Europe surgical needles market is estimated at approximately USD 142 Million in 2025 and is projected to reach approximately USD 177 Million by 2030, a compound annual growth rate of roughly 4.5 percent.

The report uses eleven dimensions: needle type, curvature, size, attachment type, suture compatibility, surgical specialty, procedure complexity, end user, procurement model, regulatory classification and distribution channel.

Europe is covered as four sub-regions, Western Europe, Southern Europe, the Nordic Region, and Central and Eastern Europe, with country and city coverage across eighteen countries in the full report.

It excludes hypodermic and syringe needles, biopsy needles and endoscopic or robotic instruments, and it covers surgical (suture) needles only.

An eyeless needle in which the suture is permanently joined to the needle, so the two are supplied as one unit. Eyed needles are the other attachment type tracked in this report.

Through direct manufacturer contracts, group purchasing organisations, hospital procurement networks, regional tender programmes and distributor-led procurement, which are the five procurement models tracked in this report.

Fourteen suppliers are profiled, including B. Braun, SUTUREX & RENODEX, Johnson & Johnson MedTech, Medtronic, Peters Surgical, Corza Medical and Teleflex, described by supplier type rather than ranked.

By a top-down derivation from published estimates for the global suture needle category and the European suture category, using analyst assumptions that are set out in the Research Methodology section.

Inquire Before Buying Request Free Sample Ask For Discount